Controlling coronavirus transmission using a mobile app to trace close proximity contacts

31 March 2020

A team of medical researchers and bioethicists at Oxford University has published results today in Science that further our understanding of coronavirus transmission.

Professor Christophe Fraser from the Big Data Institute, Nuffield Department of Medicine, a lead author on the Science paper explains, “We need a mobile contact tracing app to urgently support health services to control coronavirus transmission, target interventions and keep people safe". The project is co-led by Dr David Bonsall, who explains “The mobile app concept we’ve mathematically modelled is simple and doesn’t need to track your location; it uses a low-energy version of Bluetooth to log a memory of all the app users with whom you have come into close proximity over the last few days. If you then become infected, these people are alerted instantly and anonymously, and advised to go home and self-isolate".

Inaugural Webinar of CCOUC 10th Anniversary International Webinar Series on Health Emergency and Disaster Risk Management cum IRDR Global Research Agenda Pre-Session: Latest frontier and application of Health-EDRM within the scope of COVID-19

14 April 2021

Collaborating Centre for Oxford University and CUHK for Disaster and Medical Humanitarian Response (CCOUC) was established by the joint effort of Oxford University and The Chinese University of Hong Kong as a non-profit research centre to carry out research, training and community knowledge transfer in the area of disaster and medical humanitarian response in Greater China and the Asia-Pacific Region a decade ago on 19 April 2011.

Oxford University researchers release cheap, quick COVID-19 antibody test

6 April 2021

The new easy-to-produce test detects coronavirus spike-protein binding antibodies in people who have tested positive for COVID-19.

The RECOVERY Trial: One year on

24 March 2021

Thanks to the ground-breaking work of RECOVERY, clinicians treating patients hospitalised with severe COVID-19 now have two treatments that are known to improve survival. From having no known effective drugs when the pandemic first erupted, patients are now offered treatments that have been robustly proven to reduce death and improve other outcomes, such as the length of hospital stay and the need for mechanical ventilation.

USA, Chile and Peru interim trial data show Oxford-AstraZeneca vaccine is safe and highly effective

22 March 2021

A Phase III study of the Oxford-AstraZeneca coronavirus vaccine conducted by AstraZeneca plc in the USA, Chile and Peru has shown that vaccine is safe and highly effective, adding to previous trial data from the United Kingdom, Brazil and South Africa, as well as real-world impact data from the United Kingdom.

Professor Cecilia Lindgren appointed Director of the Big Data Institute

10 March 2021

Professor Cecilia Lindgren has been appointed as the new Director of the University of Oxford’s Big Data Institute. Professor Lindgren will take up post on 1 April 2021. She succeeds Professor Gil McVean who was the founding director of the BDI, and Interim Director, Professor Martin Landray.

Professor Sarah Gilbert awarded RSA Albert Medal

5 March 2021

NDM's Professor Sarah Gilbert has been awarded the Royal Society for Arts’ (RSA) Albert Medal for her work on the Oxford vaccine. Professor Gilbert is Professor of Vaccinology and the Oxford Project Leader for ChAdOx1 nCoV-19, a vaccine against the novel coronavirus, SARSCoV-2, with approval for use in many countries around the world.